Dr. Mojgan Taremi
Lung Cancer Specialist
Stronach Regional Health Centre
905-895-4521 Ext. 6595
Doctor of Medicine, Radiation Oncology Degree from Royal College, sub-specialty in Stereotactic Lung Radiotherapy.
Associations and Affiliations:
Canadian Association of Radiation Oncology, American Society of Radiation Oncology, Ontario Medical Association, the College of Physicians and Surgeons.
Dr. Taremi mainly focuses on lung cancer management and researches different technologies and techniques in radiotherapy. At Southlake, Dr. Taremi is currently studying lung toxicities related IMRTs (Intensity Modulated Radiation Therapy) in lung radiotherapy, and how patients can manage and control the risk factors associated with shortness of breath (dyspnea). She is the principle investigator in a PROCLAIM study where she is partnering with Princess Margaret Hospital and looking at locally advanced non-small cell lung cancer (NSCLC), the most common type of lung cancer being treated with chemo-radiotherapy.
Research Summary of Key Projects:
Some of the key projects Dr. Taremi is currently involved in look at special techniques in radiotherapy, particularly ones involving IMRT lung radiotherapy toxicity. This type of radiotherapy looks specifically at chest wall and lung toxicity.
Dr. Taremi is also involved in research regarding stereotactic lung radiotherapy and she is partnering with a research group at Princess Margaret Hospital.
Apart from studying lung cancer treatment, Dr. Taremi conducts projects regarding lung cancer prevention and how to change patient lifestyles in order to benefit their health. At Southlake, she is involved in the smoke cession program and the dyspnea clinic. She is studying alongside a nurse practitioner in order to understand what causes patients to experience shortness of breath and how to modify the symptoms.
When looking specifically at the smoking cession program at Southlake, Dr. Taremi's goal in this project is to provide education for her patients in order to help control any breathing problems they may encounter. The purpose of this program is to teach patients how to change and control their lifestyle in order to modify their risks of developing lung cancer or having it reoccur. This helps patient's undergo lung cancer treatment and improve their quality of life.
Dr. Taremi's long term research goals include trying to find better tumor control for lung cancer patients by using image guided radiotherapy and targeted radiation. This will minimize toxicity related to radiotherapy and provide a better balance between the potential toxicities and treatment goal.
Future Goals and Interest in Research
Dr. Taremi is interested in PET/CT-scan for lung radiation and would like to conduct future studies utilizing this technique in evaluating tumor/normal tissue response and prognosis after radiation treatment.
Related Articles and Publications:
Stereotactic Body Radiotherapy for Medically Inoperable Lung Cancer: Prospective, Single-Center Study Of 108 Consecutive Patients.
Surgical Salvage Following Stereotactic Body Radiotherapy for Early-Stage NSCLC